Kailix Advisors LLC lessened its holdings in shares of Constellium SE (NYSE:CSTM – Free Report) by 14.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 997,027 shares of the industrial products company’s stock after selling 174,188 shares during the quarter. Constellium makes up approximately 11.2% of Kailix Advisors LLC’s investment portfolio, making the stock its 4th largest position. Kailix Advisors LLC’s holdings in Constellium were worth $19,901,000 at the end of the most recent quarter.
Other institutional investors have also recently bought and sold shares of the company. Raymond James & Associates boosted its stake in shares of Constellium by 32.3% in the third quarter. Raymond James & Associates now owns 53,082 shares of the industrial products company’s stock valued at $966,000 after buying an additional 12,973 shares during the period. Bailard Inc. acquired a new stake in Constellium in the third quarter valued at $318,000. Mackenzie Financial Corp acquired a new stake in Constellium in the third quarter valued at $268,000. Strs Ohio acquired a new stake in Constellium in the third quarter valued at $1,004,000. Finally, Allspring Global Investments Holdings LLC increased its holdings in Constellium by 30.7% in the third quarter. Allspring Global Investments Holdings LLC now owns 11,963 shares of the industrial products company’s stock valued at $218,000 after purchasing an additional 2,809 shares during the period. Institutional investors and hedge funds own 92.59% of the company’s stock.
Constellium Stock Performance
Shares of CSTM stock traded up $0.33 during trading hours on Friday, hitting $20.70. 910,407 shares of the company were exchanged, compared to its average volume of 957,925. The firm has a fifty day simple moving average of $20.63 and a 200 day simple moving average of $18.94. The company has a current ratio of 1.31, a quick ratio of 0.52 and a debt-to-equity ratio of 2.01. Constellium SE has a 52-week low of $13.77 and a 52-week high of $23.20. The stock has a market capitalization of $2.99 billion, a price-to-earnings ratio of 23.00 and a beta of 1.71.
Analyst Upgrades and Downgrades
A number of analysts have commented on the stock. Benchmark reaffirmed a “buy” rating and set a $24.00 price target on shares of Constellium in a research report on Friday, April 19th. Deutsche Bank Aktiengesellschaft raised their price target on shares of Constellium from $21.00 to $24.00 and gave the company a “buy” rating in a research report on Tuesday, January 23rd. JPMorgan Chase & Co. decreased their price objective on shares of Constellium from $28.00 to $27.00 and set an “overweight” rating for the company in a research note on Thursday. Finally, UBS Group initiated coverage on shares of Constellium in a research note on Tuesday, January 16th. They issued a “buy” rating and a $27.00 price objective for the company. Six analysts have rated the stock with a buy rating, According to MarketBeat.com, the stock has an average rating of “Buy” and a consensus price target of $25.40.
View Our Latest Analysis on CSTM
About Constellium
Constellium SE, together with its subsidiaries, engages in the design, manufacture, and sale of rolled and extruded aluminum products for the packaging, aerospace, automotive, defense, and other transportation and industry end-markets. The company operates through three segments: Packaging & Automotive Rolled Products, Aerospace & Transportation, and Automotive Structures & Industry.
See Also
- Five stocks we like better than Constellium
- Dividend Payout Ratio Calculator
- MarketBeat Week in Review – 4/22 – 4/26
- Insider Trades May Not Tell You What You Think
- 3 Stocks Leading the U.S. Agriculture Comeback
- Roth IRA Calculator: Calculate Your Potential Returns
- How to Use Put Debit Spreads to Profit From Falling Stocks
Want to see what other hedge funds are holding CSTM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Constellium SE (NYSE:CSTM – Free Report).
Receive News & Ratings for Constellium Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Constellium and related companies with MarketBeat.com's FREE daily email newsletter.